DUBLIN–(BUSINESS WIRE)–The “Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allografts, Viscosupplements), By End-use (Hospitals, ASCs), By Application, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030. The market is expected to grow at an attractive CAGR of 4.0% from 2023 to 2030.
The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements. For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years). The product demand was reduced during the COVID-19 pandemic owing to the low volume of patient flow for chronic ailments in hospitals & clinics, abated marketing & sales activities, postponed elective surgeries, social distancing, and lockdown protocols.
For example, Anika Therapeutics notified challenges in patient enrollment for its clinical trials owing to the pandemic, which adversely impacted the company’s operating results and revenue. However, the company recovered financial performance and operations as elective surgeries restarted post-pandemic. As per the Centers for Disease Control and Prevention (CDC), approximately 78 million adults in the U.S., or 26% of the population, are projected to be diagnosed with arthritis by 2040. The risk of arthritis increases with age and is found to be more common in females.
Another risk factor is obesity. According to the CDC, the prevalence of obesity in the U.S. was estimated to be around 42.4% from 2017 to 2018. Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth. The products used in orthopedic regenerative surgery have a wide range of applications, including gout, joint pain, fibromyalgia, articular defects, osteoarthritis, joint replacement, and trauma.
This is also anticipated to contribute to the growth of the market. Key players in the market are involved in several strategic initiatives, including R&D projects to introduce new regenerative solutions for pain relief from diseases. For instance, in March 2021, Amniox Medical, Inc., received FDA clearance to proceed with a dosing study using its Investigational New Drug (IND) TTAX03- consisting of the umbilical cord and cryopreserved amniotic membrane, to alleviate facet joint osteoarthritis pain.
Companies Mentioned
- Baxter
- Zimmer Biomet
- Stryker
- Smith+Nephew
- Allosource
- Amniox Medical, Inc.
- Anika Therapeutics, Inc.
- Vericel Corporation
- Vsy Biotechnology GmbH
- Aptissen S.A
- Mimedx
Orthopedic Regenerative Surgical Products Market Report Highlights
- The viscosupplements segment held the largest market share of about 42.59% in 2022 owing to the high prevalence of orthopedic conditions, such as osteoarthritis, and increasing product availability in the market
- The allografts segment is anticipated to witness a CAGR of 4.1% during the forecast period owing to the increasing utilization of allografts
- The joint reconstruction segment held the largest revenue share of 35.66% in 2022 in the application segment due to the rising adoption of regenerative solutions in joint reconstruction
- The cartilage & tendon repair segment is estimated to grow at the fastest CAGR of 4.2% during the forecast period owing to increasing applications in geriatric patients and sports medicine
- The hospital end-use segment dominated the market and held the largest revenue share of about 49.04% in 2022 as most orthopedic treatments are performed in hospital settings
- The ambulatory surgical centers (ASCs) segment is expected to showcase the fastest CAGR of 4.1% during the forecast period
- Key players in the market are undertaking various strategic initiatives, including product development & launches, R&D, regional expansion, and distribution network expansion
- In January 2021, Stryker acquired OrthoSensor, Inc., a private company that specializes in sensor technology and musculoskeletal care
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $4.14 billion |
| Forecasted Market Value (USD) by 2030 | $5.63 billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 Orthopedic Regenerative Surgical Products Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Orthopedic Regenerative Surgical Products Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.3 Penetration And Growth Prospect Mapping, 2022
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
3.6 Regulatory Framework
3.7 Technology Trend Analysis
3.8 Product Pipeline Analysis
3.9 Osteoarthritis Prevalence (2018 to 2030)
Chapter 4 Orthopedic Regenerative Surgical Products Market: COVID-19 Impact Analysis
Chapter 5 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Product, 2018 – 2030 (USD Million)
Chapter 6 Orthopedic Regenerative Surgical Products Market Analysis, By Application, 2018 – 2030 (Revenue, USD Million)
Chapter 7 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By End-Use, 2018 – 2030 (USD Million)
Chapter 8 Orthopedic Regenerative Surgical Products Market: Regional Market Analysis 2018 – 2030 (USD Million)
Chapter 9 Orthopedic Regenerative Surgical Products Market – Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/h94nwp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900